Lucas Laursen investigates. This year, midway through Argentina's 2005–2015 Strategic Plan for Biotechnology, a long-stalled update of the Seed Law circulating in Buenos Aires may finally reach ...

ATHENS, Ga. & SAN JOSE, Calif.--(BUSINESS WIRE)--Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored vaccines that harness ...

"In addition, small protein regulators like NirP1 could in future be deployed in 'green' and 'blue' biotechnology for targeted control of the metabolism." More information: Alexander Kraus et al ...

US-based clinical-stage intranasal vaccine company, Blue Lake Biotechnology’s pediatric nasal vaccine for respiratory syncytial virus (RSV), BLB201, was safe and effective for paediatric ...

Research analysts at Leerink Partnrs upped their Q4 2024 earnings estimates for shares of bluebird bio in a research report issued on Wednesday, January 22nd. Leerink Partnrs analyst M. Foroohar now ...